Plasma osteopontin predicts inflammatory bowel disease activities

Area of Science:

• Immunology
• Gastroenterology
• Biochemistry

Background:

• Osteopontin (OPN), a glycoprotein, is implicated in various inflammatory diseases.
• Its precise role in inflammatory bowel disease (IBD) remains debated.
• Understanding OPN's systemic immune involvement is crucial for IBD research.

Purpose of the Study:

• To investigate the association between plasma osteopontin (OPN) levels and systemic immune markers in IBD.
• To compare OPN levels and their correlations with cytokines in ulcerative colitis (UC) and Crohn's disease (CD) patients.
• To elucidate the differential roles of OPN in the inflammatory processes of UC and CD.

Main Methods:

• Simultaneous measurement of plasma osteopontin (OPN) and 17 cytokines in 24 UC patients, 17 CD patients, and 23 healthy controls.
• Assessment of clinical parameters and disease activity indices.
• Statistical analysis to determine correlations between OPN levels, cytokines, and clinical data.

Main Results:

• Plasma OPN levels were significantly elevated in both UC and CD patients compared to controls.
• OPN levels correlated significantly with clinical activity indices in UC and CD patients.
• In UC, OPN showed significant correlations with multiple cytokines (IL-1β, IL-4, IL-5, IL-6, IL-7, IL-13, IFN-γ, TNF-α, GM-CSF).
• In CD, OPN correlation with cytokines was limited, with significance only observed for IL-8.

Conclusions:

• Elevated plasma osteopontin (OPN) is a marker of systemic inflammation in inflammatory bowel disease (IBD).
• Distinct patterns of OPN-cytokine relationships suggest different underlying inflammatory mechanisms in ulcerative colitis and Crohn's disease.
• These findings highlight OPN's potential as a biomarker and underscore the heterogeneity of inflammatory states in IBD.